<unk>  is an antimanlaric that is FDA approved for the treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients of 5 kg bodyweight and above.   Common adverse reactions include headache, anorexia, dizziness, asthenia, arthralgia and myalgia.
Artemether and lumefantrin
Artemether/lumefantrine
Thonzylamine hydrochloride and chlophedianol hydrochloride
Atovaquone and proguanil hydrochloride
Methenamine and sodium salicylate
Sodium sulfate, potassium sulfate and magnesium sulfate
Galantamine hydrobromide
Streptozocin